Winfried Römer

This study identifies collagen VI as a key ECM component in ccRCC stroma, showing its role in shaping tumor structure, function, and immune response, with implications for TKI therapy.

The paper develops a new chimeric lectin, Janus lectin, with enhanced valency and specificity for fucose and galactose, and demonstrates its application in forming protocell-like structures.

This study identifies alpha-synuclein accumulation as a mediator of podocyte injury in Fabry disease, showing that targeting SNCA improves lysosomal function beyond enzyme replacement therapy.